Clough Capital Partners’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,137,764
| Closed | -$3.63M | – | 130 |
|
|
2022
Q1 | $3.63M | Sell |
1,137,764
-168,862
| -13% | -$539K | 0.28% | 72 |
|
|
2021
Q4 | $3.75M | Sell |
1,306,626
-260,700
| -17% | -$748K | 0.25% | 67 |
|
|
2021
Q3 | $6.22M | Hold |
1,567,326
| – | – | 0.38% | 61 |
|
|
2021
Q2 | $9.34M | Buy |
1,567,326
+215,013
| +16% | +$1.28M | 0.51% | 66 |
|
|
2021
Q1 | $16.4M | Buy |
1,352,313
+19,916
| +1% | +$242K | 0.73% | 44 |
|
|
2020
Q4 | $19.4M | Buy |
1,332,397
+19,111
| +1% | +$278K | 1.38% | 25 |
|
|
2020
Q3 | $14.9M | Buy |
+1,313,286
| New | +$14.9M | 1.07% | 29 |
|